¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • effective quantum number
    À¯È¿¾çÀÚ¼ö
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®, À¯È¿½ÅÀåÇ÷·ù·®
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷ÀåÀ¯·®, À¯È¿½ÅÀåÇ÷ÀåÀ¯·®
  • effective temperature index
    À¯È¿¿ÂµµÁö¼ö
  • effectiveness
    1. À¯È¿µµ 2. È¿À² 3. À¯¿ëµµ
  • effector
    1. È¿°ú±â 2. ÀÛµ¿Ã¼ 3. È¿°úÀÎÀÚ 4. ÀÛ¿ëÀÎÀÚ
  • efficiency
    1. È¿À², È¿À²¼º 2. ´É·ü
  • efficient coitus
    À¯È¿¼º±³
  • endoenzyme
    ³»È¿¼Ò
  • endonuclease
    ÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, ¿£µµ´ºÅ¬·¹¾ÆÁ¦
  • endopeptidase
    ÆéƼµå³»ºÎºÐÇØÈ¿¼Ò, ¿£µµÆéƼ´Ù¾ÆÁ¦
  • endpoint PCR
    ³¡Á¡ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • epimerase
    ÀÔüÀ̼ºÃ¼È¿¼Ò
  • ectoenzyme
    ¿ÜÈ¿¼Ò
  • esterase
    ¿¡½ºÅ׸£ºÐÇØÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • endopeptidase
    ÆéƼµå³»ºÎºÐÇØÈ¿¼Ò, ¿£µµÆéƼ´Ù¾ÆÁ¦
  • esterase
    ¿¡½ºÅ׸£ºÐÇØÈ¿¼Ò
  • exoenzyme
    ¼¼Æ÷¿ÜÈ¿¼Ò, ±Õü¹ÛÈ¿¼Ò
  • exonuclease
    Çٻ긻´ÜºÐÇØÈ¿¼Ò, ¿¢¼Ò´ºÅ¬·¹¾ÆÁ¦
  • exopeptidase
    ÆéƼµå¸»´ÜºÐÇØÈ¿¼Ò, ¿¢¼ÒÆéƼ´Ù¾ÆÁ¦
  • effective mass
    À¯È¿Áú·®
  • effective value
    À¯È¿°ª
  • effective alveolar ventilation
    À¯È¿ÆóÆ÷ȯ±â, À¯È¿ÆóÆ÷ȯ±â·®
  • effective blood volume
    À¯È¿Ç÷¾×·®
  • effective circulating volume
    À¯È¿¼øÈ¯¿ëÀû
  • effective dose equivalent
    À¯È¿¼±·®ÇØ´ç·®
  • effective filtration pressure
    À¯È¿¿©°ú¾Ð
  • effective membrane resistance
    À¯È¿¸·ÀúÇ×
  • effective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½¼öÁØ, ½ÇÁ¦°¨°¢¼ÒÀ½
  • effective quantum number
    À¯È¿¾çÀÚ¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • anhydrase
    ¾ÈÈ÷µå¶óÁ¦, Å»¼öÈ¿¼Ò
  • anhydrase
    ¾ÈÈ÷µå¶óÁ¦<Å»¼öÈ¿¼Ò>.
  • antagonistic effect
    ±æÇ×È¿°ú
  • antibody to histidyl tRNa synthetase
    È÷½ºÆ¼µô tRNa ÇÕ¼ºÈ¿¼Ò¿¡ ´ëÇÑ Ç×ü
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú.
  • antienzyme dentifrice
    Ç×È¿¼Ò¼º Ä¡Á¦(ù÷ý£áÈàõöÍð¥).
  • antioxidant effect
    Ç×»êÈ­È¿°ú(¡­üùÍý).
  • antioxidase
    Ç×»êÈ­È¿¼Ò(ù÷ß«ûùý£áÈ).
  • antiprotease
    Ç״ܹéÈ¿¼Ò(ù÷Ó±ÛÜý£áÈ)
  • antitoxemic effect
    Ç×µ¶Ç÷ÁõÈ¿°ú.
  • antitussive effect
    ÁøÇØÈ¿°ú(òåú¦üùÍý).
  • antiyeast substance
    Ç×È¿¸ð¹°Áú.
  • apoenzyme
    ¾ÆÆ÷È¿¼Ò.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • combined effect
    º´¿ëÈ¿°ú(ܱéÄüùÍý).
  • combined effect
    º´¿ëÈ¿°ú
  • combustion efficiency
    ¿¬¼ÒÈ¿À²(¡­üùëÒ).
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • committed effective dose equivalent
    ¿¹Å¹À¯È¿¼±·®´ç·®
  • compton effect
    ÄÞÅæÈ¿°ú
  • concentration effect
    ³óÃàÈ¿°ú, ³óµµÈ¿°ú(¡­üùÍý).
  • concentration effect
    ³óÃàÈ¿°ú, ³óµµÈ¿°ú(¡­üùÍý).
  • congenital deficiency of glucuronyl transfe ra se
    ¼±Ãµ¼º ±Û·çÄí·Ð»ê Àü À§È¿¼Ò°áÇÌÁõ(¡­ï®êÈý£áÈÌÀù¹ñø).
  • constitutive enzyme
    ±¸¼ºÈ¿¼Ò(ϰà÷ý£áÈ).
  • constitutive enzyme
    ±¸¼ºÀûÈ¿¼Ò (±âº»)
  • convertase
    Àüȯȿ¼Ò(ï®üµý£áÈ).
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦.
  • cophosphorylase
    ÀλêÈ­È¿¼Ò º¸È¿¼Ò(ìÝß«ûùý£áÈÜÍý£áÈ), ÄÚÆ÷½ºÆ÷¸±¶óÁ¦.
  • cost-effectiveness analysis
    ºñ¿ë-È¿°úºÐ¼®.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • hydrophobic effect
    ¼Ò¼ö È¿°ú(áÂâ©áÂâ©)
  • hyperchromic effect
    Èí±¤Áõ°¡ È¿°ú (ýåÎÃñòÊ¥üùÍý)
  • hypochromic effect
    Èí±¤ °¨¼Ò È¿°ú(ýåÎÃÊõá´üùÍý)
  • immobilized enzyme
    °íÁ¤ È¿¼Ò(ͳïÒý£áÈ)
  • immunoenzymometric assay
    ¸é¿ªÈ¿¼ÒÃøÁ¤(Øóæ¹ý£áÈö´ïÒ) ¾Æ½êÀÌ
  • incision enzyme
    Àý°³ È¿¼Ò(ï·ËÒý£áÈ)
  • indicator enzyme
    Áö½ÃÈ¿¼Ò(ò¦ãÆý£áÈ)
  • indispensable enzyme
    ºÒ°¡°á È¿¼Ò(ÝÕʦÌÀý£áÈ)
  • induced enzyme
    À¯µµÈ¿¼Ò(ë¯Óôý£áÈ)
  • inducible enzyme
    À¯µµ°¡´ÉÈ¿¼Ò(ë¯ÓôʦÒöý£áÈ)
  • induction effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
  • inductive effect
    À¯µµÈ¿°ú(ë¯ÓôüùÍý)
  • insoluble enzyme
    ºÒ¿ë¼ºÈ¿¼Ò(ÝÕéÁàõý£áÈ)
  • integration efficiency
    ÅëÇÕ È¿À²(÷Öùêüù×Ë)
  • interconvertible enzyme
    »óÈ£Àüȯȿ¼Ò(ßÓû»ï®üµý£áÈ)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • isotopic effect
    µ¿À§ ¿ø¼Ò È¿°ú
  • lacrimalin ´©¼±¿¡¼­ ¾ò¾îÁö´Â ¹°Áú·Î ÃÖ·ç ÀÛ¿ëÀÌ ÀÖ´Ù.

    lacrimase

    ´©¼± È¿¼Ò
  • lact(o)- Á¥, À¯Áó ¶Ç´Â À¯»ê°úÀÇ °ü°è¸¦ ³ªÅ¸³»´Â Á¢µÎ¾î.

    lactacidase

    À¯»ê È¿¼Ò
    À¯»ê±Õ¿¡ µé¾î ÀÖ´Â È¿¼Ò·Î¼­, À¯»êÀ» »ý»êÇÏ´Â °Í.
  • lactase
    ¶ôŸ¾ÆÁ¦, À¯´ç È¿¼Ò, À¯´ç ºÐÇØ È¿¼Ò
    1. ¶ôÅä¿À½º
  • lactate dehydrogenase
    ¶ôÆ®»ê Å»¼ö¼Ò È¿¼Ò, ¶ôÆ®»ê µ¥È÷µå·Î°Ô³ªÁ¦
  • lactic dehydrogenase
    ¶ôÆ®»ê Å»¼ö¼Ò È¿¼Ò, À¯»ê Å»¼ö¼Ò È¿¼Ò, Á¥»ê Å»¼ö¼Ò È¿¼Ò
  • late effet
    ÈÄÀ¯ È¿°ú
    ¾î¶² ¾à¹°À» »ç¿ëÇßÀ» ¶§ ½ÇÁ¦ ±× ¾à¹°ÀÇ È¿°ú´Â ¾Æ´ÏÁö¸¸ µû¶ó¼­ ¹ß»ýÇÏ´Â ¾ç¼º Áõ»ó.
  • lethal effect
    Ä¡»ç È¿°ú
  • lipase
    Áö¹æ ºÐÇØ È¿¼Ò, ¸®ÆÄÁ¦, ¸®ÆÄ¾ÆÁ¦
    1. °£, ÃéÀå, À§ ¹× ±× ¹ÛÀÇ ¼ÒÈ­ ±â°ü ¶Ç´Â ¾î¶² Á¾·ùÀÇ ½Ä¹°¿¡ µé¾îÀÖ´Â ¿¡½ºÅ×¶óÁ¦. 2. ±Û¸®¼¼¸° ¿¡½ºÅÍ °¡¼öºÐÇØ È¿¼Ò. Æ®¶óÀÌ ±Û¸®¼¼¶óÀÌµå ¹× ÀÎ ÁöÁúÀÇ Áö¹æ»ê°ú ±Û¸®¼¼¸° »çÀÌÀÇ ¿¡½ºÅÍ °áÇÕÀ» °¡¼öºÐÇØÇÏ´Â °ÍÀ» Ã˸ÅÇÏ´Â ±¤¹üÀ§ÇÏ°Ô Á¸ÀçÇÏ´Â È¿¼Ò±º. 3. Áö¹æÀ» Áö¹æ»ê°ú ±Û¸®¼¼·Ñ·Î °¡¼öºÐÇØÇÏ´Â È¿¼Ò. ¸®ÆÄ¾ÆÁ¦´Â µ¿¹°ÀÇ ¼ÒÈ­ È¿¼Ò·Î¼­ À§ ¾×, ÀÌÀÚ ¾×, Àå¾× ¼Ó¿¡ ºÐºñµÇ°í Æó, ½ÅÀå, ºÎ½Å, Áö¹æ Á¶Á÷, ÅÂ¹Ý µîÀÇ °¢Á¾ Á¶Á÷¿¡µµ ÀÖÀ¸¸ç, ½Ä¹°¿¡¼­´Â ¹Ð, ¾ÆÁֱ, Äá µîÀÇ Á¾ÀÚ¿Í °õÆÎÀÌ, È¿¸ð, ¼¼±Õ µî¿¡µµ ³Î¸® µé¾î ÀÖ°í, ¿ìµÎ ¹ÙÀÌ·¯½º¿¡µµ µé¾î ÀÖ´Ù. ±× ¹Û¿¡ Ư¼öÇÑ ¸®ÆÄ¾ÆÁ¦·Î¼­´Â ¸®Æ÷ ´Ü¹éÁú ¸®ÆÄ¾ÆÁ¦°¡ µ¿¹°ÀÇ Ç÷¾× µî¿¡ Á¸ÀçÇϸ鼭 ¸®Æ÷ ´Ü¹éÁúÀ» Çü¼ºÇÏ´Â Áß¼º Áö¹æ¿¡ Àß ÀÛ¿ëÇÑ´Ù. ÇìÆÄ¸°¿¡ ÀÇÇØ ÀÌ È¿¼Ò°¡ Ȱ¼ºÈ­µÈ´Ù. ¸®ÆÄ¾ÆÁ¦´Â Áß¼º Áö¹æ¿¡ ÀÛ¿ëÇÏ¿© Æ®¸®¾Æ½Ç ±Û¸®¼¼¸®µå¿¡¼­ µð¾Æ½Ç ±Û¸®¼¼¸®µå¿Í ¸ð³ë¾Æ½Ç ±Û¸®¼¼¸®µå¸¦ °ÅÃļ­ Áö¹æ»ê°ú ±Û¸®¼¼¸°À¸·Î ºÐÇØÇÑ´Ù. ¼ºÁúÀº Àç·á¿¡ µû¶ó ´Ù¸£°í, ¶Ç È¿¼Ò·Î¼­ÀÇ È­ÇÐÀû Ư¡Àº ±âÁúÀÌ µÇ´Â Áß¼º Áö¹æ¿¡ µû¶ó ´Ù¸£´Ù. µ¿¹°¼º ¸®ÆÄ¾ÆÁ¦´Â
  • lipolytic enzyme
    Áö¹æ ºÐÇØ È¿¼Ò
  • liver isozyme fraction
    °£ È¿¼Ò À¯ºÐ
  • longitudinal effect
    Á¾ È¿°ú, Á¾Àû È¿°ú
  • lysosomal enzyme
    ¸®¼ÒÁ» È¿¼Ò, ¿ëÇØ ¼Òü È¿¼Ò
  • M.E.D.
    ÃÖ¼Ò À¯È¿·®, ÃÖ¼Ò È«¹Ý ¹ßÀû·®
    1. minimal effective doseÀÇ ¾àÀÚ. 2. ÃÖ¼Ò È«¹Ý ¹ßÀû·®. minimum erythemaÀÇ ¾àÀÚ.
  • MAO
    ¸ð³ë ¾Æ¹Î »êÈ­ È¿¼Ò
    monoamine oxldaseÀÇ ¾àÀÚ.
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
  • disutility
    ºñÈ¿¿ë;¹«ÀÍ;À¯ÇØ
  • domino efect
    µµ¹Ì³ë È¿°ú !
  • double blind
    (ÀÇ)(¾àÀÇ È¿°ú¸¦ ÆÇÁ¤ÇÏ´Â ¹æ¹ý¿¡¼­)2Áß ¸Í°ËÀÇ
  • doublebline test
    ÀÌÁß¸Í °Ë»ç¹ý(½Å¾à È¿°úÀÇ °Ë»ç¹ý)
  • drug design
    (¾à)¾àÁ¦ ¼³°è(À¯È¿¼ºÀ» ³ôÀ̱â À§ÇÑ Á¾ÇÕÀû °³¹ß °ËÅä
  • dutiful
    Ãæ½ÇÇÑ;º»ºÐÀ» ÁöŰ´Â;È¿¼º½º·¯¿î
  • duty
    Àǹ«;º»ºÐ;Ã¥ÀÓ;Á÷¹«;ÀÓ¹«;ÀÏ;°æÀÇ;°ü¼¼;Á¶¼¼;È¿À²;Á¾¹«;°ü¼¼;...ÀÇ ´ë¿ëÀÌ µÇ´Ù
  • echo chamber
    (¹æ¼Û)ÀÜÇâ½Ç(¿¬Ãâ»ó ÇÊ¿äÇÑ ¿¡ÄÚ È¿°ú¸¦ ¸¸µé¾î ³»´Â ¹æ)
  • echo effect
    ¸Þ¾Æ¸® È¿°ú(¾î¶² ÀÏÀÌ µÚ´Ê°Ô µÇÇ®ÀÌ µÇ°Å³ª,±× °á°ú°¡ ´Ê°Ô ³ªÅ¸³ª´Â µîÀÇ Çö»ó)
  • ecological efficiency
    (»ýÅÂ)»ýÅ ȿ·Â;»ýÅÂÀû È¿À²(¹°Áú,¿¡³ÊÁöÀÇ ÀüÀÌ È¿À²)
  • ectoenzyme
    (»ýÈ­)ü¿Ü È¿¼Ò;¼¼Æ÷ÀÇ È¿¼Ò(ü¿Ü¿¡ ºÐºñµÈ)
  • effect
    °á°ú;¿µÇâ;È¿°ú;À¯È¿;´À³¦;Àλó;ºû±òÀÇ ¹èÇÕ;ÃëÁö;´ëÀÇ;¿Ü°ü;°á°ú¸¦ °¡Á®¿À´Ù;´Ù;¸ñÀûÀ» ÀÌ·ç´Ù
  • effective
    À¯È¿ÇÑ;È¿°úÀûÀÎ;ÀλóÀûÀÎ;»ç½Ç»óÀÇ;½ÇÁ¦ÀÇ;È¿·ÂÀÖ´Â;µ¿¿ø°¡´ÉÇÑ;º´·Â;´«¿¡ ¶ç´Â
  • effective aperture
    (±¤)(·»ÁîÀÇ) À¯È¿ ±¸°æ
  • effective demand
    (°æ)À¯È¿ ¼ö¿ä
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 10
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 10
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á